Acute MPTP Treatment Impairs Dendritic Spine Density in the Mouse Hippocampus
Among the animal models of Parkinson’s disease (PD), the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned mouse model has shown both dopaminergic (DA) damage and related motor control defects, as observed in patients with PD. Recent studies have suggested that the DA system interacts wit...
Main Authors: | Poornima D. E. Weerasinghe-Mudiyanselage, Mary Jasmin Ang, Mai Wada, Sung-Ho Kim, Taekyun Shin, Miyoung Yang, Changjong Moon |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/11/7/833 |
Similar Items
-
Changes in the Neuronal Architecture of the Hippocampus in a 6-Hydroxydopamine-Lesioned Rat Model of Parkinson Disease
by: Bohye Kim, et al.
Published: (2022-11-01) -
Loss of RAB39B does not alter MPTP-induced Parkinson’s disease-like phenotypes in mice
by: Zijie Wang, et al.
Published: (2023-01-01) -
Dendritic spine loss deep in the neocortex and dendrite distortion with diffusion disturbances occur early in experimental pneumococcal meningitis
by: Dario Baronti, et al.
Published: (2023-01-01) -
Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
by: Valeria V. Goloborshcheva, et al.
Published: (2022-09-01) -
The Discovery of Dendritic Spines by Cajal
by: Rafael eYuste
Published: (2015-04-01)